RXRX earnings: a negative outcome, -7.1%

On November 9, 2023, Recursion Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.1% in the window around the event. It had already run -21.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.